The Horizon 3.0 Transcranial Magnetic Stimulation (TMS) Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex. The ...

And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...

JMP Securities analyst Daniel Stauder reiterated a Buy rating on Neuronetics (STIM – Research Report) today and set a price target of ...

The Horizon Inspire System. [Image courtesy of Magstim] Magstim announced today that the FDA cleared its next-generation ...

Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid ...

While traditional multistop options have served many shippers well, there is an even more impactful option on the market ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Greenbrook Tms (GBNHF) has released an update. Greenbrook TMS Inc. shareholders have overwhelmingly approved the company’s acquisition by Neuronetics, Inc., paving the way for a significant corporate ...

Analysts anticipate Edap TMS to report an earnings per share (EPS) of $-0.16. The market awaits Edap TMS's announcement, with ...